Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hadfield

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Clinical Otolaryngology and Allied Sciences|August 1, 1997
Treatment of otitis media with effusion in children with primary ciliary dyskinesiaP J Hadfield, J M Rowe-Jones, A Bush, et al.
American Journal of Clinical Oncology|November 21, 2023
Genomic and Molecular Characteristics of Ovarian CarcinosarcomaKristy Ramphal, Matthew J Hadfield, Christina M Bandera, et al.
The Journal of Infection|May 7, 2013
Detection of IgG antibodies in sera from patients with Cryptosporidium parvum and Cryptosporidium hominisRachel M Chalmers, Kristin Elwin, John Cheesbrough, et al.
International Journal of Pediatric Otorhinolaryngology|February 1, 2003
The effect of aryepiglottoplasty for laryngomalacia on gastro-oesophageal refluxPandora J Hadfield, David M Albert, C Martin Bailey, et al.
Parasitology Research|March 11, 2014
Validation of fragment analysis by capillary electrophoresis to resolve mixed infections by Cryptosporidium parvum subpopulationsJoaquín Quílez, Stephen J Hadfield, Ana Ramo, et al.
International Journal for Parasitology|May 29, 2012
Cryptosporidium viatorum n. sp. (Apicomplexa: Cryptosporidiidae) among travellers returning to Great Britain from the Indian subcontinent, 2007-2011Kristin Elwin, Stephen J Hadfield, Guy Robinson, et al.
Parasitology Research|January 4, 2011
Zoonotic linkage and variation in Cryptosporidium parvum from patients in the United KingdomRachel M Chalmers, Richard P Smith, Stephen J Hadfield, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 27, 2002
Making a difference to practice: clinical benchmarking. Part 2J Ellis, A Cooper, D Davies, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Clinical Otolaryngology and Allied Sciences|August 1, 1997
Treatment of otitis media with effusion in children with primary ciliary dyskinesiaP J Hadfield, J M Rowe-Jones, A Bush, et al.
American Journal of Clinical Oncology|November 21, 2023
Genomic and Molecular Characteristics of Ovarian CarcinosarcomaKristy Ramphal, Matthew J Hadfield, Christina M Bandera, et al.
The Journal of Infection|May 7, 2013
Detection of IgG antibodies in sera from patients with Cryptosporidium parvum and Cryptosporidium hominisRachel M Chalmers, Kristin Elwin, John Cheesbrough, et al.
International Journal of Pediatric Otorhinolaryngology|February 1, 2003
The effect of aryepiglottoplasty for laryngomalacia on gastro-oesophageal refluxPandora J Hadfield, David M Albert, C Martin Bailey, et al.
Parasitology Research|March 11, 2014
Validation of fragment analysis by capillary electrophoresis to resolve mixed infections by Cryptosporidium parvum subpopulationsJoaquín Quílez, Stephen J Hadfield, Ana Ramo, et al.
International Journal for Parasitology|May 29, 2012
Cryptosporidium viatorum n. sp. (Apicomplexa: Cryptosporidiidae) among travellers returning to Great Britain from the Indian subcontinent, 2007-2011Kristin Elwin, Stephen J Hadfield, Guy Robinson, et al.
Parasitology Research|January 4, 2011
Zoonotic linkage and variation in Cryptosporidium parvum from patients in the United KingdomRachel M Chalmers, Richard P Smith, Stephen J Hadfield, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|April 27, 2002
Making a difference to practice: clinical benchmarking. Part 2J Ellis, A Cooper, D Davies, et al.
Pageof 13